Literature DB >> 12368277

Cellular conditioning and activation of beta-catenin signaling by the FPB prostanoid receptor.

Hiromichi Fujino1, Dinesh Srinivasan, John W Regan.   

Abstract

FP prostanoid receptors have been identified as two isoforms named FP(A) and FP(B). We have shown that the FP(B) isoform, but not the FP(A), activates beta-catenin-mediated transcription. We now report that the mechanism of this FP(B)-specific activation of beta-catenin signaling occurs in two steps. The first is a conditioning step that involves an agonist-independent association of the FP(B) receptor with phosphatidylinositol 3-kinase followed by constitutive internalization of a receptor complex containing E-cadherin and beta-catenin. This constitutive internalization conditions the cell for subsequent beta-catenin signaling by increasing the cellular content of cytosolic beta-catenin. The second step involves agonist-dependent activation of Rho followed by cell rounding. Because of the conditioning step, this agonist-dependent step results in a stabilization of beta-catenin and activation of transcription. Although stimulation of the FP(A) isoform activates Rho and induces cellular shape change, it does not activate beta-catenin signaling, because the FP(A) does not undergo constitutive internalization and does not condition the cell for beta-catenin signaling. The cellular conditioning described here for the FP(B) illustrates the potential of the receptor to alter the signaling environment of a cell even in the absence of agonist and has general significance for understanding G-protein-coupled receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368277     DOI: 10.1074/jbc.M209393200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Beyond TGF-beta: a prostaglandin promotes fibrosis.

Authors:  Mitchell A Olman
Journal:  Nat Med       Date:  2009-12       Impact factor: 53.440

2.  FP-receptor gene silencing ameliorates myocardial fibrosis and protects from diabetic cardiomyopathy.

Authors:  Wen-yuan Ding; Lin Liu; Zhi-hao Wang; Meng-xiong Tang; Yun Ti; Lu Han; Lei Zhang; Yun Zhang; Ming Zhong; Wei Zhang
Journal:  J Mol Med (Berl)       Date:  2014-02-07       Impact factor: 4.599

3.  Role of the ERC motif in the proximal part of the second intracellular loop and the C-terminal domain of the human prostaglandin F2alpha receptor (hFP-R) in G-protein coupling control.

Authors:  Andrea Pathe-Neuschäfer-Rube; Frank Neuschäfer-Rube; Gerhard P Püschel
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

4.  LRP6 mediates cAMP generation by G protein-coupled receptors through regulating the membrane targeting of Gα(s).

Authors:  Mei Wan; Jun Li; Katie Herbst; Jin Zhang; Bing Yu; Xiangwei Wu; Tao Qiu; Weiqi Lei; Charlotta Lindvall; Bart O Williams; Hairong Ma; Fengjie Zhang; Xu Cao
Journal:  Sci Signal       Date:  2011-03-15       Impact factor: 8.192

Review 5.  LRP5 and LRP6 in development and disease.

Authors:  Danese M Joiner; Jiyuan Ke; Zhendong Zhong; H Eric Xu; Bart O Williams
Journal:  Trends Endocrinol Metab       Date:  2013-01       Impact factor: 12.015

Review 6.  Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium.

Authors:  Kurt J Sales; Henry N Jabbour
Journal:  Reproduction       Date:  2003-11       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.